XML 71 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Financial Information of Parent Company (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule of Parent-only Balance Sheets
The following table presents the parent-only balance sheets of GoodRx Holdings, Inc.:
December 31,
(in thousands, except par values)20232022
Assets
Cash$$
Other assets164 — 
Investment in subsidiary, net of distributions761,790 814,822 
Total assets$761,959 $814,827 
Liabilities and stockholders' equity
Total liabilities$$— 
Stockholders' equity
Preferred stock, $0.0001 par value
— — 
Common stock, $0.0001 par value
40 40 
Additional paid-in capital2,219,321 2,263,322 
Accumulated deficit(1,457,403)(1,448,535)
Total stockholders' equity761,958 814,827 
Total liabilities and stockholders' equity$761,959 $814,827 
Schedule of Parent-only Statement of Operations
The following table presents the parent-only statements of operations of GoodRx Holdings, Inc.:
Year Ended December 31,
(in thousands)202320222021
Equity in loss of subsidiary$(8,868)$(32,828)$(25,254)
Net loss$(8,868)$(32,828)$(25,254)
Schedule of Parent-only Statement of Cash Flows
The following table presents the parent-only statements of cash flows of GoodRx Holdings, Inc.:
Year Ended December 31,
(in thousands)202320222021
Cash flows from operating activities
Net loss$(8,868)$(32,828)$(25,254)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Equity in loss of subsidiary8,868 32,828 25,254 
Changes in assets and liabilities:
Other assets(164)80 (23)
Other current liabilities— (87)
Net cash (used in) provided by operating activities(163)80 (110)
Cash flows from investing activities
Distribution from subsidiary162,287 113,117 22,777 
Net cash provided by investing activities162,287 113,117 22,777 
Cash flows from financing activities
Repurchases of Class A common stock(103,974)(101,721)— 
Proceeds from exercise of stock options5,941 9,159 35,021 
Employee taxes paid related to net share settlement of equity awards(65,481)(20,635)(57,688)
Proceeds from employee stock purchase plan1,390 — — 
Net cash used in financing activities(162,124)(113,197)(22,667)
Net change in cash— — — 
Cash
Beginning of period
End of period$$$